Afexa Life Sciences Inc. — Investor Relations & Filings
About Afexa Life Sciences Inc.
Afexa Life Sciences Inc. was a health-science company focused on the research, development, and manufacturing of naturally derived pharmaceuticals and health products. The company specialized in creating over-the-counter supplements designed to prevent or relieve symptoms of common ailments. A core component of its operations was the patented ChemBioPrint discovery and standardization technology, which enabled the development of effective and safe medicines from natural sources. Afexa's primary consumer brands included COLD-FX , a best-selling cold and flu support supplement, and COLDSORE-FX .
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.PDF | 2011-12-14 | English | |
| Other securityholders documents - English.pdf | 2011-12-14 | English | |
| Material change report - English.pdf | 2011-10-19 | English | |
| Material change report - English.pdf | 2011-10-04 | English | |
| Material document(s).pdf | 2011-09-02 | English | |
| Other securityholders documents - English.pdf | 2011-08-24 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines …
|
CNTA | GB | Manufacturing |
|
Century Therapeutics, Inc.
Develops iPSC-derived allogeneic cell therapies for cancer …
|
IPSC | US | Manufacturing |
|
Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovasc…
|
CRNO | SE | Manufacturing |
|
CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeu…
|
CERO | US | Manufacturing |
|
CERUS CORP
Develops pathogen inactivation technology to reduce transfu…
|
CERS | US | Manufacturing |
|
Cessatech A/S
A biotech company developing medicines for children's acute…
|
CESSA | DK | Manufacturing |
|
CF PharmTech
Develops and manufactures inhalation drugs and delivery sys…
|
2652 | CN | Manufacturing |
|
CF PharmTech, Inc.
Specialty pharmaceutical company developing complex inhalat…
|
2652 | HK | Manufacturing |
|
CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomic…
|
083790 | KR | Manufacturing |
|
CG Oncology, Inc.
Develops bladder-sparing oncolytic immunotherapies for urol…
|
CGON | US | Manufacturing |
Afexa Life Sciences Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44707/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44707 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44707 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44707 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44707}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Afexa Life Sciences Inc. (id: 44707)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.